IBRX
Moving with its group (XBI +2.3%)
- IBRX +2.27% on the last session vs SPY +0.12%: +2.1 pts of stock-specific move.
- The biotech ETF (XBI) +2.3% (+2.2 pts vs SPY): the stock moved with its group.
- Filing: 8-K: Reg FD disclosure (item 7.01) (filing)
- 1 Reddit mentions in the past 24 hours, 78% positive over the week · today's pace is 1.8× its recent daily average.
- 1 analyst action in the past 10 days (0 positive, 0 negative); latest: HC Wainwright & Co. reiterated Buy, target $15.00.
- 4 insider or congressional trades in the past 30 days.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
- Activity: volume on pace for 1.8× its 20-day average.
Bargain & stretch prices
Prices IBRX only reaches with set odds, from its own recent swings. Odds, not a forecast.
| Today | Next 5 sessions | |
|---|---|---|
| Stretch sell side |
10.33 +4.3% reached 3 in 10 days reached today |
10.88 +9.8% reached 3 in 10 weeks |
| Now | 10.14 · prior close 9.91 | |
| Bargain buy side |
9.50 -4.1% reached 3 in 10 days |
9.02 -8.9% reached 3 in 10 weeks |
More patient or more eager
| Bargain | Reached | Stretch | Reached | |
|---|---|---|---|---|
| Today | ||||
| Patient | 9.37 | 2 in 10 days | 10.48 | 2 in 10 days |
| Balanced | 9.50 | 3 in 10 days | 10.33 | 3 in 10 days |
| Eager | 9.62 | 4 in 10 days | 10.20 | 5 in 10 days |
| Next 5 sessions | ||||
| Patient | 8.75 | 2 in 10 weeks | 11.22 | 2 in 10 weeks |
| Balanced | 9.02 | 3 in 10 weeks | 10.88 | 3 in 10 weeks |
| Eager | 9.28 | 4 in 10 weeks | 10.58 | 5 in 10 weeks |
"3 in 10 days" means the price was reached on about 3 of every 10 days like this one. Patient prices are further away and come less often; eager ones are closer and come more often. From IBRX's daily swings (about 4.3% a day lately), anchored on the Oct 14 close. The odds were measured on 10 years of S&P 500 prices (they move about 3 points from year to year with the market: bargain prices come more often in falling years, stretch prices in rising ones), and where a situation below changed them consistently (in at least 8 of 10 years), they are adjusted and marked. In those tests, waiting for the bargain price did no better on average than buying at the close: what you save when it comes, you pay when it doesn't.
Situations on the Oct 14 close
Big drop and big gain: among IBRX's own worst or best 10% of daily moves, as on the Aftermath tab. The past times are history: in our tests, how a stock did after its earlier times did not predict the next one, and across the S&P 500 none of these situations leaned up or down except, weakly, an all-time high followed by a big drop. Not advice.
Price ladder
| All-time closing high Feb 22, 2021 |
42.25 +316.9% |
| Highest analyst target | 16.00 +57.9% |
| Mean analyst target | 13.75 +35.7% |
| Lowest analyst target | 12.00 +18.4% |
| 52-week closing high Feb 24, 2026 |
11.55 +14.0% |
| Stretch, next 5 sessions | 10.88 +7.4% |
| Now | 10.14 |
| Previous close Oct 14, 2026 |
9.91 -2.2% |
| Bargain, next 5 sessions | 9.02 -11.0% |
| 50-day average | 8.53 -15.9% |
| 200-day average | 7.56 -25.4% |
| 52-week closing low Dec 30, 2025 |
1.98 -80.5% |
Closing prices (all-time = the 11 years Yahoo has). Percentages are the distance from now. These are levels people watch, not levels the price has to respect. Not advice.